Alzheimer’s Disease

On-Demand Webinar: Methylene Blue & Clinical Opportunities

2025-11-21T15:32:38-06:00June 25th, 2025|Categories: Continuing Education, Alzheimer's Disease, Alzheimers/Dementia, Clinical Research, compounding, COVID-19, Patient Counseling, Pharmacology|Tags: , , , , , |

Missed the live webinar on November 19, 2025? It’s now available on-demand so you can access the full program whenever it fits your schedule.

Curious about the latest research and clinical uses of Methylene Blue? This program explores its emerging role in treating conditions like Lyme disease, dementia, Alzheimer’s, post-COVID syndrome, and more—plus offers practical compounding tips for pharmacy teams.

This talk aims to illuminate the evolving landscape of Methylene Blue’s applications in healthcare, specifically focusing on its novel utilization for enhancing patient outcomes. It delves into recent advancements and promising research for conditions such as Lyme disease, dementia, bladder health, Alzheimer’s disease, post-COVID syndrome, and anti-aging/nootropic effects.

The program also covers Methylene Blue’s pharmacology, including mechanisms of action, pharmacokinetics, and pharmacodynamics. Learners will outline evidence-based prescribing protocols and dosing strategies and learn to recognize common adverse reactions while reviewing appropriate management strategies for patient safety.

Pharmacists can expect insights into how this versatile compound contributes to improved patient care, supporting a deeper understanding of its potential impact on healthcare outcomes. Practical compounding process tips are included to benefit Pharmacy Technicians and improve lab efficiency.

Learning Objectives for Pharmacists and Pharmacy Technicians:

  • Describe recent advancements and research findings on methylene blue’s effectiveness in managing conditions such as Lyme disease, dementia, bladder health, Alzheimer’s disease, and COVID-19.

  • Recognize the potential anti-aging and nootropic effects of methylene blue and their relationship to cognitive health.

  • Outline the pharmacological profile of methylene blue, including mechanisms of action, pharmacokinetics, and pharmacodynamics.

  • List key prescribing considerations and general dosing strategies for methylene blue in clinical settings.

  • Identify common adverse reactions to methylene blue and recall strategies for promoting patient safety.

  • Identify practical tips and techniques for working with methylene blue in a compounding lab setting that support efficient workflow.

SPECIAL PRICING FOR PHARMACY TECHNICIANS AND STUDENT PHARMACISTS

Q: Who should attend this webinar?
Pharmacy professionals, including clinical pharmacists compounding pharmacists, pharmacy technicians, and other health care professionals interested in methylene blue.

Q: Will I earn CE credit?
Yes. This activity is ACPE-accredited for pharmacists and pharmacy technicians.

ACA Methylene Blue Webinar for Pharmacists – CE Credits

Whether you’re looking to deepen your understanding of Methylene Blue’s pharmacology or stay informed on its emerging clinical applications, this on-demand webinar delivers timely, practical insight for pharmacists and pharmacy technicians. Registration is below.

What attendees said:

  • This was a well presented webinar!
  • “Good format, presenter well informed, good information.”
  • Provided an in-depth review of the full drug profile.”

Note: It is not necessary to create a Lecture Panda account to register for this webinar.

Additional On-Demand CE Available

Low Dose Naltrexone continuing educationa


The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this knowledge-based program for 1 contact hour (0.1 CEU) of continuing education credit for pharmacists and pharmacy technicians.

Nutrition & Wellness Faculty Meeting: “Alzheimer’s #1 Concern of Patients”

2025-10-31T19:41:27-05:00July 6th, 2023|Categories: Nutrition, Alzheimer's Disease, Community Pharmacy, Pharmacy Practice|Tags: , , , , |

Date:  Tuesday, August 15, 2023
Time:  12:30 PM Eastern / 11:30 AM Central / 10:30 AM Mountain / 9:30 AM Pacific

Topic: “Alzheimer’s #1 Concern of Patients”

Host: Dr. Quentin Srnka, PharmD, MBA, FACA  

Panelists:
Dr. Hillary Howell, PharmD, FACA, CCN
Chuck Schneider, MBA

Join us for a 1 hour webinar on “Alzheimer’s #1 Concern of Patients”. Alzheimer’s is the disease people of all ages are most worried about. Join the panelists as they discuss Alzheimer’s disease, a relevant and emotional topic for patients.

August 15 Faculty Meeting Graphic (1)

This meeting will be recorded

Loading…

Our Panelists:

Dr. Hillary Howell, PharmD, FACA, CCN worked as a pharmacy technician until graduating high school in 1998. Her passion for medicine led her to enroll in the Doctor of Pharmacy program at Ferris State University and graduated in 2004. Shortly after graduating, she married her high school sweetheart and took a position as a retail staff pharmacist at a local pharmacy chain. This ultimately led to a manager position with the same company.

Hillary has two children, Hunter and Tanner, which she adores. 10 years into her position as a manager, her husband James was diagnosed with a rare type of cancer, leiomyosarcoma of the prostate. During his journey, the family decided to look into alternative treatments using both conventional and alternative therapies. Sadly, James’ journey ended 18 months later.

As a single mother, Hillary decided to take her career in a new direction. She opened Michigan’s first integrative cash based pharmacy, Apothecary & Co, in 2019, focusing on helping others to find their root cause instead of applying a “bandaid”. Apothecary & Co proudly specializes in compounding, point of care testing, and functional medicine consulting. Since opening in 2019, Hillary received her Certified Clinical Nutrition designation in 2021. She is currently pursuing a certification program through the Institute for Functional Medicine. Besides the love for functional medicine, her other passion is medicinal herbalism leading her to complete coursework through Rosemary Gladstar’s The Science of Art and Herbalism program.

Chuck Schneider, MBA is the Co-founder of the Point of Care Testing Institute and is the Director of Pharmacy at Cognivue, a neuroscience testing company.

For the past decade, Chuck has worked closely with pharmacists and independent pharmacy owners to help them increase their service lines and profitability.  Prior to joining Cognivue, Chuck was the chief revenue officer at Pharmacy Development Services and more recently at Ananda Professional where he led commercial operations.

Chuck received his MBA from the Thunderbird School of International Management.  Chuck lives in Lexington, Kentucky.  He enjoy running, cooking on Sunday nights, and visiting National Parks.

Go to Top